BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Kengreal (Cangrelor) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Kengreal (Cangrelor)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07225842-1266@assetmemo.bio
DTSTAMP:20261121T004044Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Kengreal (Cangrelor): Phase 4 readout est. (NCT07225842)
DESCRIPTION:Kengreal (Cangrelor)\, phase 4.\nStudy: The Bridging Antiplatel
 et Therapy With Cangrelor 2 Study\nEstimated primary completion: September
  2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout dat
 e\, and it can move.\nDrug page: https://assetmemo.bio/drug/cangrelor#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07225842
URL:https://assetmemo.bio/drug/cangrelor#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
